These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1320362

  • 21. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
    Clement JJ, Tanaka SK, Alder J, Vojtko C, Beyer J, Hensey D, Ramer N, McDaniel D, Chu DT.
    Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
    [Abstract] [Full Text] [Related]

  • 22. Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    J Antimicrob Chemother; 1991 Jun; 27(6):793-9. PubMed ID: 1657857
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
    Chin NX, Novelli A, Neu HC.
    Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
    Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y, Kashimoto S, Yoshida H, Kojima T, Ohue T.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1167-73. PubMed ID: 2802544
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991 Aug; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 26. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of HSR-903, a new quinolone.
    Takahashi Y, Masuda N, Otsuki M, Miki M, Nishino T.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1326-30. PubMed ID: 9174193
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS, Ahlén S.
    Chemotherapy; 1993 Jun; 39(1):32-5. PubMed ID: 8383030
    [Abstract] [Full Text] [Related]

  • 29. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
    Bauernfeind A.
    J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of sparfloxacin.
    Chin NX, Gu JW, Yu KW, Zhang YX, Neu HC.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):567-71. PubMed ID: 2039209
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [Abstract] [Full Text] [Related]

  • 32. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
    Yoshida T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):793-800. PubMed ID: 8388199
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone.
    Marshall SA, Jones RN.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948
    [Abstract] [Full Text] [Related]

  • 34. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
    Ballow CH, Jones RN, Johnson DM, Deinhart JA, Schentag JJ.
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of T-3761, a new fluoroquinolone.
    Muratani T, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
    [Abstract] [Full Text] [Related]

  • 36. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
    Wakabayashi E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):594-601. PubMed ID: 8203860
    [Abstract] [Full Text] [Related]

  • 37. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
    [Abstract] [Full Text] [Related]

  • 38. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
    Ito T, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
    [Abstract] [Full Text] [Related]

  • 39. [In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC].
    Inoue M, Kuga A, Kaieda S, Hosaka M, Kitasato H, Sato Y, Okamoto R, Eda T, Hoshino K, Seto I.
    Jpn J Antibiot; 2000 Sep; 53(9):593-608. PubMed ID: 11214999
    [Abstract] [Full Text] [Related]

  • 40. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE, Henderberg A, Sanders CV.
    Diagn Microbiol Infect Dis; 1989 Sep; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.